Arvinas (ARVN) Net Cash Flow (2017 - 2026)
Arvinas' (ARVN) quarterly Net Cash Flow came in at -$55.6 million in Q1 2026, down 185.13% year-on-year from $65.3 million in Q1 2025, and down 234.3% quarter-over-quarter from $41.4 million in Q4 2025.
Arvinas (ARVN) Net Cash Flow (2017 - 2026) Analysis & Trends
Arvinas' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$55.6 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 185.13% year-over-year to -$55.6 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 150.4% increase from a year earlier, with the FY2025 full-year figure at $42.4 million, up 119.57% from the prior year.
- Net Cash Flow slipped to -$55.6 million in Q1 2026 per ARVN's latest filing, from $41.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $198.0 million in Q4 2023 and bottomed at -$223.7 million in Q1 2024.
- The 5-year median for Net Cash Flow is $15.3 million (2024), against an average of -$1.5 million.
- Across the five-year window, Net Cash Flow soared 485.96% in 2023 and slumped 557.46% in 2024, its largest moves.
- Year by year, Net Cash Flow stood at -$51.3 million in 2022, then surged by 485.96% to $198.0 million in 2023, then slumped by 92.27% to $15.3 million in 2024, then soared by 170.59% to $41.4 million in 2025, then tumbled by 234.3% to -$55.6 million in 2026.
- Per Business Quant, the three latest ARVN Net Cash Flow figures stand at -$55.6 million (Q1 2026), $41.4 million (Q4 2025), and -$13.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | -55.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.60 Mn |
| Mar 31, 2026 | -55.60 Mn |
| Dec 31, 2025 | 41.40 Mn |
| Dec 31, 2025 | 41.40 Mn |
| Sep 30, 2025 | -13.40 Mn |
| Sep 30, 2025 | -13.40 Mn |
| Jun 30, 2025 | 33.90 Mn |
| Jun 30, 2025 | 33.90 Mn |
| Mar 31, 2025 | -19.50 Mn |
| Mar 31, 2025 | -19.50 Mn |
| Dec 31, 2024 | 15.30 Mn |
| Dec 31, 2024 | 15.30 Mn |
| Sep 30, 2024 | -75.10 Mn |
| Sep 30, 2024 | -75.10 Mn |
| Jun 30, 2024 | 66.80 Mn |
| Jun 30, 2024 | 66.80 Mn |
| Mar 31, 2024 | -223.70 Mn |
| Mar 31, 2024 | -223.70 Mn |
| Dec 31, 2023 | 198.00 Mn |
| Dec 31, 2023 | 198.00 Mn |